States increasingly struggling to cover the rising cost of popular GLP-1 drugs like Wegovy, Ozempic and Zepbound are ...

Trump cutbacks were supposedly aimed at administrators. But scientists in food and drug-testing labs and policy experts who ...

Drug trials are vital to medicine, but what of those taking part? Jennie Erin Smith's moving new book about what happened in ...

The state’s second-largest insurer is grappling with heightened health care spending and a market that is increasingly unable ...

A bipartisan effort in the Senate Judiciary Committee has led to the passage of two bills designed to lower prescription drug ...

Medicare clients typically pay either a fixed dollar amount (known as a co-payment) or a percentage of a drug’s list price ...

Up to $3 billion in pharmaceuticals currently used in the United States (U.S.) depend on Canadian manufacturing, according to ...

The pharmaceutical company lowers costs of medications for everyday consumers—but Trump’s tariffs might make that more ...

Evaluating current formulary access for the 25 drugs selected for Drug Price Negotiation in Medicare Part D shows several selected drugs have ...

As managed care pharmacy navigates rapid transformations in policies, high-cost drug strategies, and innovative therapies, ...

As health care costs continue to rise, artificial intelligence (AI)-driven solutions are emerging as a powerful tool for ...